This Million Position Signals Conviction in Biotech Stock
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
Understanding risks and rewards helps you decide whether Zero Based Budgeting strengthens or complicates your financial plan.
28,655 articlesWhen a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
OpenAI leads the 2026 IPO chatter, with Stripe and Consensys jockeying for position as investors weigh odds, valuatio...
The U.S. reimposes naval blockade amid intensified strikes and Iranian threats, sending oil prices higher and sparkin...
An executive move at Cirrus Logic involving 3,000 shares draws attention to insider trading signals. This article bre...
A harsh winter trimmed fishing days and boosted costs for Maine’s lobster sector, even as 2025 revenue stayed above $...
A new release from Anthropic is triggering a global debate over hidden safeguards. Critics say Claude Fable 5 quietly...
Federal health officials tie lettuce from mexico sold to Taco Bell and other outlets to a cyclospora outbreak spannin...
A $1 million 401(K) balance can still bring big tax and Medicare costs. Here are five actionable moves to protect you...
As markets swing in 2026, savers confront whether their 401(k) targets match reality. This report breaks down age-by-...
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
Amazon is emerging as an undervalued winner in the AI hyperscaler war, backed by a 30 percent price-performance edge ...
Benchmark analysts cheer Strategy’s pivot to STRC as the primary funding engine for bitcoin accumulation, signaling a...